...
首页> 外文期刊>Libyan journal of medicine >Impediment of selenite-induced cataract in rats by combinatorial drug laden liposomal preparation
【24h】

Impediment of selenite-induced cataract in rats by combinatorial drug laden liposomal preparation

机译:组合药物负载脂质体制剂对大鼠亚硒酸盐性白内障的阻碍

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Cataract is the leading cause of blindness globally with surgery being the only form of treatment. But cataract surgery is accompanied by complications, chiefly intra-ocular infections. Hence, preventive nanoformulations may be extremely beneficial. In the present study, novel chitosan-coated liposomal formulations encapsulating a combination of drugs, lanosterol and hesperetin were prepared and characterized. The combinatorial liposomes were prepared by thin film evaporation active extrusion method. The characterization of liposomes was done by transmission electron microscopy, zeta potential, encapsulation efficiency, stability, cytotoxicity and in vitro release studies. The main difference between the chitosancoated and uncoated combinatorial liposomes is the release of drugs as indicated by the in vitro release studies. The slow and sustained release of the drugs from chitosan-coated ones as against the burst release from uncoated indicates an increased retention time for combinatorial drugs in cornea. This leads to a delay in progression of cataract as seen from in vivo studies. Cytotoxicity studies indicate no cell toxicity of the coating of chitosan or the combination of drugs. Stability studies indicate that there were almost no changes in size, zeta potential and polydispersity index values of the combinatorial liposomes upon storage at room temperature for 60 days. Another important study is the estimation of antioxidant defense system. The estimated values of glutathione reductase, malondialdehyde and chief antioxidant enzymes point toward an upregulation of antioxidant defense system. From the results, it may be concluded that novel chitosan-coated combinatorial liposomes are effective in delaying or preventing of cataract.
机译:白内障是全球失明的主要原因,手术是唯一的治疗形式。但是白内障手术会伴有并发症,主要是眼内感染。因此,预防性纳米制剂可能是极其有益的。在本研究中,制备并表征了包封药物,羊毛甾醇和橙皮素的组合的新型壳聚糖包衣脂质体制剂。通过薄膜蒸发主动挤出法制备组合脂质体。通过透射电子显微镜,ζ电势,包封效率,稳定性,细胞毒性和体外释放研究完成了脂质体的表征。壳聚糖包衣的和未包衣的组合脂质体之间的主要区别是药物的释放,如体外释放研究所示。从壳聚糖包衣的药物缓慢和持续释放,与未包衣的爆发释放相比,表明组合药物在角膜中的保留时间增加。如体内研究所见,这导致白内障进展的延迟。细胞毒性研究表明,壳聚糖涂层或药物组合对细胞没有毒性。稳定性研究表明,在室温下保存60天后,组合脂质体的大小,ζ电位和多分散指数值几乎没有变化。另一个重要的研究是抗氧化防御系统的估计。谷胱甘肽还原酶,丙二醛和主要抗氧化酶的估计值表明抗氧化防御系统的上调。从结果可以得出结论,新型壳聚糖包衣的组合脂质体可有效延迟或预防白内障。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号